Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Groundbreaking scientific collaboration gives UK academia access to compounds to advance medical research
-
KOMBOGLYZE™ receives marketing authorisation in the European Union for adult patients with Type 2 diabetes
-
AstraZeneca commits an additional $100 million to venture capital arm MedImmune Ventures
-
CAPRELSA™ (vandetanib) receives positive CHMP opinion in the European Union for treating advanced medullary thyroid cancer
-
SATURN demonstrated effect of intensive statin treatment on reducing atherosclerosis
-
AstraZeneca and Targacept announce first top-line Phase III results for TC-5214 as an adjunct treatment in patients with major depressive disorder
-
AstraZeneca PLC Third quarter and nine months results 2011
-
US Food and Drug Administration extends action date for dapagliflozin by three months
-
AstraZeneca to present new healthcare economics data demonstrating cost-effectiveness of BRILIQUE at ISPOR EU
-
AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat serious Gram-negative bacterial infections
Latest articles and press releases
All of our latest press releases and articles are available to explore
